Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: Preliminary results of the BECOME trial

Journal of Neuroimaging

Volumn 15, Issue 3, 2005, Pages 289-290

  Wolansky, Leo J ^a   Haghighi, Mohammad H ^a   Sevdalis, Evangelia ^a   Cook, Stuart D ^a   Sethi, Nilay ^a   Liu, Jiang ^a   Joseph, George ^a   Tulloch, Kimberly ^a   Cadavid, Diego ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

High dose gadolinium; Multiple sclerosis; Serial scanning; Triple dose gadolinium

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GLATIRAMER; INTERFERON BETA SERINE;

ANAPHYLAXIS; CELLULITIS; DRUG EFFECT; DRUG SAFETY; EDEMA; HEADACHE; HUMAN; HYPERSENSITIVITY REACTION; HYPESTHESIA; IMAGE ENHANCEMENT; INJECTION SITE REACTION; LETTER; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE; SENSORY DYSFUNCTION; THROMBOPHLEBITIS;

ADJUVANTS, IMMUNOLOGIC; CONTRAST MEDIA; DRUG ADMINISTRATION SCHEDULE; GADOLINIUM DTPA; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PEPTIDES; SAFETY;

EID: 20844438866     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1177/1051228405277339     Document Type: Letter

References (5)

1. Wolansky LJ, Bardini JA, Cook SD, Zimmer AE, Sheffet A, Lee HJ. Triple-dose vs. single-dose gadoteridol in multiple sclerosis patients. J Neuroimaging 1994;4:141-145.
2. Wolansky LJ, Finden SG, Chang R, et al. Gadoteridol in multiple sclerosis patients: a comparison of single and triple dose with immediate vs. delayed imaging. Clin Imaging 1998;22:385-392.
3. Wolansky L, Cadavid D, Cook S, et al. 3 Tesla magnetic resonance imaging comparison of interferon beta-1b and glatiramer acetate: a randomized, single-blind study in relapsing-remitting multiple sclerosis. Poster presented at: the annual meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis/European Committee for Treatment and Research in Multiple Sclerosis; September 18-21, 2002; Baltimore, MD.
4. Filippi M, Rovaris M, Capra R. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Brain 1998;121:2011-2020.
5. Goldstein HA, Kashanian FK, Blumetti RF, Holyoak WL, Hugo FP, Blumenfield DM. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials. Radiology 1990;174:17-23.